Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| MPZL1 | O95297 | Myelin protein zero-like protein 1 (Protein zero-related) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediation | 1 | 0.50 | |||
| MRGRF | Q96AM1 | Mas-related G-protein coupled receptor member F (Mas-related gene F protein) (G-protein coupled receptor 140) (G-protein coupled receptor 168) | G-protein coupled receptorsPredicted intracellular proteinsPredicted membrane proteins | 7 | Other mediation | 1 | 0.50 | |||
| MRP1 | P33527 | Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter) | Cancer-related genesDisease related genesEnzymes | 17 | Gout | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| MRP3 | O15438 | ATP-binding cassette sub-family C member 3 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3) | Cancer-related genesEnzymesMetabolic proteins | 17 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| MUC18 | P43121 | Cell surface glycoprotein MUC18 (Cell surface glycoprotein P1H12) (Melanoma cell adhesion molecule) (Melanoma-associated antigen A32) (Melanoma-associated antigen MUC18) (S-endo 1 endothelial-associated antigen) (CD antigen CD146) | CD markersPlasma proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| MYO9A | B2RTY4 | Unconventional myosin-IXa (Unconventional myosin-9a) | Disease related genesHuman disease related genesPlasma proteins | 1 | Receptor-signaling mediation | 1 | 0.50 | |||
| NAC1 | P32418 | Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1) | FDA approved drug targetsMetabolic proteinsPredicted intracellular proteins | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| NCAM1 | P13591 | Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56) | Cancer-related genesCD markersPlasma proteins | 1 | Acute myeloid leukaemiaMultiple myelomaMyelodysplastic syndrome | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| NCAM2 | O15394 | Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) | Plasma proteinsPredicted membrane proteins | 1 | Other mediation | 1 | 0.50 | |||
| NCKX2 | Q9UI40 | Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2) | 11 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| NCKX4 | Q8NFF2 | Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4) | 10 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||||
| NEO1 | Q92859 | Neogenin (Immunoglobulin superfamily DCC subclass member 2) | Cancer-related genesPlasma proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| NK1R | P25103 | Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Abnormal micturitionAcute diabete complicationAcute upper respiratory infection | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| NK2R | P21452 | Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2) | 7 | Abnormal micturitionAcute/chronic painAnxiety disorder | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | |||
| NKG2A | P26715 | NKG2-A/NKG2-B type II integral membrane protein (CD159 antigen-like family member A) (NK cell receptor A) (NKG2-A/B-activating NK receptor) (CD antigen CD159a) | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.50 | ||||
| NKG2C | P26717 | NKG2-C type II integral membrane protein (CD159 antigen-like family member C) (NK cell receptor C) (NKG2-C-activating NK receptor) (CD antigen CD159c) | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.50 | ||||
| NKPD1 | Q17RQ9 | NTPase KAP family P-loop domain-containing protein 1 | Predicted membrane proteins | 3 | Other mediation | 1 | 0.50 | |||
| NMBR | P28336 | Neuromedin-B receptor (NMB-R) (Epididymis tissue protein Li 185a) (Neuromedin-B-preferring bombesin receptor) | 7 | Immune mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| NMUR2 | Q9GZQ4 | Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1) | G-protein coupled receptorsPredicted membrane proteins | 7 | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | |||
| NPFF2 | Q9Y5X5 | Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor) | 7 | Receptor-signaling mediation | 1 | 0.50 | ||||
| NPT2A | Q06495 | Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (NaPi-3) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1) | Disease related genesHuman disease related genesMetabolic proteins | 8 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| NPT2B | O95436 | Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2) | Cancer-related genesDisease related genesHuman disease related genes | 8 | Lung cancerOvarian cancer | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||
| NSMA | O60906 | Sphingomyelin phosphodiesterase 2 (EC 3.1.4.12) (Lyso-platelet-activating factor-phospholipase C) (Lyso-PAF-PLC) (Neutral sphingomyelinase) (N-SMase) (nSMase) (nSMase1) | EnzymesMetabolic proteinsPredicted intracellular proteins | 2 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| NTAL | Q9GZY6 | Linker for activation of T-cells family member 2 (Linker for activation of B-cells) (Membrane-associated adapter molecule) (Non-T-cell activation linker) (Williams-Beuren syndrome chromosomal region 15 protein) (Williams-Beuren syndrome chromosomal region 5 protein) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | |||
| NTCP5 | Q5PT55 | Sodium/bile acid cotransporter 5 (Na(+)/bile acid cotransporter 5) (Solute carrier family 10 member 5) | Predicted membrane proteinsTransporters | 9 | Fusion and delivery mediation | 1 | 0.50 |